Mr Damien Hong Yew Hui
Chief Operating Officer, SCRI
Mr Damien Hong is the Chief Operating Officer at SCRI. As the COO, he is responsible for managing operations strategy and policies, creating value through innovation and aligning employees with corporate goals. He oversees implementation of the strategic direction of SCRI and is involved in day-to-day operations.
He spearheaded the IT infrastructure development which was a key enabler in the highly-publicised CHloroquine for Influenza prevention (CHIP) Trial. Published in Lancet, the Trial received international interest for being the first to utilise the internet to recruit over 1,000 patients efficiently and cost-effectively.
Besides holding an appointment at the Duke-National University of Singapore Graduate Medical School’s Office of Clinical Sciences, Damien serves as the council member at the Singapore Workforce Development Agency (WDA) Clinical Research Industry Skills and Training Council. He also spearheads various initiatives in SingHealth, in areas including the clinical trial operations/coordination, data management and research technology.